Author

Seda Akgün

Düsseldorf University Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Björn StorkiD· 2 shared Karina Stephanie KringsiD· 2 shared María José MendiburoiD· 2 shared Sebastian WesselborgiD· 2 shared Alessandro PrigioneiD· 1 shared Annabelle Friedrich· 1 shared Annika ZinkiD· 1 shared Arndt BorkhardtiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Björn StorkORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Canonical autophagy remains inactive in induced pluripotent stem cells and neuronal progenitor cells following DNA damage induced by BPDE or etoposide.

Seda Akgün, Padmashri Naren, Thomas Lenz, Annika Zink, Karina Stephanie Krings, Sebastian Wesselborg, María José Mendiburo, Alessandro Prigione, Kai Stühler, Björn Stork

This study shows that canonical autophagy remains inactive in iPSCs and NPCs under DNA damage, despite a functional autophagy machinery and responsive DNA damage response.

Scientific Reports · Jun 8, 2026Peer-reviewedCell Biology

Small-molecule inhibitor of C-terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells

Céline David, Yadong Sun, Vitalij Woloschin, Melina Vogt, Niklas Dienstbier, Annabelle Friedrich, Karina Stephanie Krings, David Schlütermann, Lena Berning, Beate Lungerich, Seda Akgün, María José Mendiburo, Christoph G. W. Gertzen, Arndt Borkhardt, Sebastian Wesselborg, , Björn Stork

This paper introduces a C-terminal HSP90 dimerization inhibitor, VWK147, which induces cell death in cisplatin-resistant cancer cells and synergizes with mTOR inhibition to enhance therapeutic efficacy.

Cell Death and Disease · Dec 23, 2025Peer-reviewedCell Biology